Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06308614

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Sexual Dysfunction, Physiological Clinical Trial

Official title:
A Phase 2, Randomized, Double-blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects With Female Sexual Arousal Disorder

Clinical Trial Summary

The goal of this clinical trial is investigating estetrol (E4) in women after menopause, suffering from sexual arousal disorder. The main question it aims to answer is: is 20 mg estetrol monohydrate effective in the treatment of sexual arousal disorder in women after their menopause. Participants will visit the clinic 7 times and complete a daily diary while receiving estetrol or placebo for 12 weeks. Placebo is a pill that looks the same as estetrol but has no active ingredient. Researchers will compare estetrol and placebo to see if estetrol has an effect on the sexual arousal of the participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Sexual Dysfunction, Physiological
  • Sexual Dysfunctions, Psychological
Clinical Trial Details
NCT number NCT06308614
Study type Interventional
Source Estetra
Contact Clinical Study Leader
Phone +32 (0)4 349 28 22
Email clinical.trials@mithra.com
Status Recruiting
Phase Phase 2
Start date January 29, 2024
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01021670 - An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride Phase 4
Completed NCT00324948 - Topical Alprostadil for Female Sexual Arousal Disorder Phase 2
Recruiting NCT02624648 - Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women Phase 1
Completed NCT05692960 - Women's Interventions for Sexual Health: WISH N/A
Completed NCT01188720 - Sexual Health on Antidepressants Through Physical Exercise N/A
Completed NCT00692419 - Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients N/A
Completed NCT01063881 - The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy Phase 3
Completed NCT00451165 - Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery N/A
Recruiting NCT04604951 - Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury N/A
Recruiting NCT04512287 - PRP for Treatment of Peyronie's Disease Phase 2
Completed NCT02381912 - Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer N/A
Completed NCT00698035 - Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients Phase 2
Completed NCT00443248 - Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)). Phase 1
Completed NCT00443027 - Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women. Phase 1
Completed NCT03241524 - Consistency of Questionnaires to Evaluating Sexual Functions in Young Healthy Women N/A
Terminated NCT03018106 - Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction Phase 4
Completed NCT04364841 - Body Image and Sexuality After Bariatric Surgery
Completed NCT03592121 - Study to Investigate the Effect of AB-101 in Breast Cancer Survivors Early Phase 1
Completed NCT00482664 - The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder. Phase 2
Recruiting NCT05456919 - Quality of Sexual Function in BRCA Mutated Women